Banca Mediolanum (BMED) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
8 Jan, 2026Executive summary
Net income for Q1 2025 rose 10% year-over-year to €243.3M, driven by strong business fundamentals, resilient commercial momentum, and robust performance fees despite a decline in net interest income.
Total net inflows reached €3.77B (+23% YoY), with managed asset inflows up 71% to €2.01B; April 2025 set a new record for monthly managed asset inflows.
Customer base expanded to over 1.96M (+2% YoY), supported by network growth and promotional initiatives.
Loans granted in Q1 totaled €849M (+51% YoY), and general insurance gross premiums rose 26% YoY to €53.3M.
Assets under administration reached €140.3B, up 1% from year-end and 11% YoY.
Financial highlights
Net commission income grew 9% YoY to €316.2M, while net interest income fell 18% YoY to €180M due to rate environment and deposit promotions.
Contribution margin was €495M; operating margin stable at €279M.
Management and investment management fees increased 13% YoY to €410.5M.
Market effects contributed €52M (+106% YoY); performance fees were €39M (+32% YoY).
Profit before tax rose 11% to €330M; extraordinary items were limited (-€1.1M).
Outlook and guidance
2025 guidance: managed asset net inflows around €7.5B, NII to decrease ~5% YoY, cost/income ratio below 40%, cost of risk below 20bps, and base dividend to increase.
NII expected to improve sequentially: -18% in Q1, -14% in H1, -8% in nine months, -5% for full year.
Guidance assumes further deposit promotions in H2, already factored into NII outlook.
Dividend for 2025 anticipated to rise above the 2024 base of €0.75.
Latest events from Banca Mediolanum
- Record net income, strong asset growth, and a 25% higher dividend highlight a standout year.BMED
Q4 20253 Feb 2026 - Net income up 24% to EUR 449.9M, assets under administration EUR 129.5B, CET1 at 23.7%.BMED
Q2 20242 Feb 2026 - Net income up 18% to €674.3M, with record assets and higher interim dividend.BMED
Q3 202415 Jan 2026 - Record net income of €1.12B, €10.44B inflows, and 42% higher dividend proposed.BMED
Q4 20248 Jan 2026 - Net income up 8% to €726M, assets at €150.4B, and interim dividend raised to €0.60/share.BMED
Q3 20258 Nov 2025 - Net income up 6% to €477.3M, with record assets, strong inflows, and robust capital ratios.BMED
Q2 20251 Nov 2025